$1,000 minimum order|Contact us for questions

Tesamorelin
Out of Stock
Growth HormoneLyophilized Powder

Tesamorelin

10mg · 2ml

SKU: tesamorelin-10mg

Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH) that activates pituitary GHRH receptors to increase endogenous growth hormone release and downstream IGF-1 production. It preserves natural feedback mechanisms while supporting enhanced lipolysis, protein synthesis, and metabolic signaling, particularly targeting visceral adipose tissue reduction.


Product Specifications

Strength

10mg

Volume / Qty

2ml

Form

Lyophilized Powder

Suggested Retail Price

$75.00

Dosing Guide

Recommended Dose

1-2 mg daily

Route

Subcutaneous

Frequency

Daily

Note: FDA-approved for HIV lipodystrophy. Evening dosing.

Clinician Access Required

Sign in to view clinician pricing & place orders

Tesamorelin is available exclusively to verified clinicians under IRB-approved research protocol PPRN-001-2025.

Out of Stock

Get notified when Tesamorelin is back

We'll send you a one-time email the moment this product is restocked.

Per-batch COA verifiedcGMP / ISO 9001 / 503A/503B sourcedIRB-protected research use

IRB-Approved Research Protocol

PPRN-001-2025 ·IRCM-2025-467

Approved December 3, 2025 · Principal Investigator: Dr. M. Scott Mortensen, MD, MPAS, MLT

cGMP & ISO 9001
503A/503B Sources
Per-Batch
COA Tested
MD-Led
Clinical Oversight
50-State
Licensed
Most PopularBundle Pricing Available

Save up to 80% with the 10,000 Growth Bundle

Tesamorelin is included in this clinic-tier package. Bundle includes higher volume in weight loss, mitochondrial health, longevity, and tissue repair with 1 free Tirz 15mg + 1 free Reta 15mg as a bonus.

Bundle Price:$10,000
Wholesale Value:~$10,958
Patient Retail:~$50,000+

For Clinicians

Clinical Reference

Pharmacology, safety, monitoring, and dosing reference for Tesamorelin. Always individualize based on patient context.

Mechanism of Action

Receptor / Target

Stabilized GHRH(1-44) analog; binds pituitary GHRH receptor

Half-Life

~26 minutes (subcutaneous)

Onset of Action

15 minutes for GH pulse; 12 weeks for visceral fat reduction

Metabolism

Hepatic and renal proteolysis

Cautions & Contraindications

Contraindicated In

  • Active malignancy
  • Pregnancy (Category X)
  • Hypopituitarism, pituitary tumor, or recent pituitary surgery
  • Hypersensitivity to tesamorelin or mannitol

Use Caution With

  • Glucose intolerance and type 2 diabetes
  • Fluid retention and arthralgias common in first 8 weeks
  • Discontinue if no clinical benefit after 6 months

Suggested Labs to Monitor

IGF-1

Baseline / 6 weeks

Maintain within age-appropriate normal range; reduce dose if elevated.

Fasting glucose, HbA1c

Baseline / 12 weeks

Lipid panel

Baseline / 12 weeks

Tesamorelin reduces triglycerides and visceral fat.

Lab interpretation guidance comes from peer-reviewed literature. Always individualize based on patient context.

Reconstitution Calculator

Calculate exactly how many units to draw on a U-100 insulin syringe for your target dose. Pre-filled with Tesamorelin defaults — adjust as needed.

Total peptide in the vial (e.g. 10mg)

Volume of BAC water used to reconstitute

Single-injection dose in micrograms

Draw to

5.0units on a U-100 syringe

Per mL

5000 mcg

Doses per vial

~40

Always double-check reconstitution math. This tool is for reference — clinician supervision required.

Plumb DISCOVER

What Tesamorelin targets

Patient goals, biomarkers, and wearable signals this peptide addresses. Powers the future Plumb AI protocol engine.

Patient Goals

Weight LossLean MassLongevity

Biomarkers Tracked

IGF-1Lipid PanelHbA1c

Wearable Signals

Deep Sleep

Related Products

Back to All Peptides